Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
  1. 10-Q Report Quarterly Report
  2. 4 Grant or award Chief Commercial Officer acquired 168 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 168 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 1,159 shares (grant or award)
  5. 4 Grant or award Chief Strategy Officer acquired 156 shares (grant or award)
  6. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,703 shares (grant or award)
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 4 Grant or award Chief Medical Officer acquired 3,846 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 2,224 shares (grant or award)
  10. 4 Grant or award Chief Commercial Officer acquired 2,326 shares (grant or award)
  11. 4 Grant or award Chief Strategy Officer acquired 3,946 shares (grant or award)
  12. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 3,846 shares (grant or award)
  13. 4 Grant or award Chief Medical Officer acquired 168 shares (grant or award)
  14. 4 Grant or award Chief Commercial Officer acquired 168 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 1,159 shares (grant or award)
  16. 4 Grant or award Chief Strategy Officer acquired 156 shares (grant or award)
  17. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,703 shares (grant or award)
  18. 8-K Event Other events
  19. 4 Planned sale Director sold 15,545 shares at $10.29 ($159,958)
  20. 144 Insider Sale of Securities

Page 1 of 43 · 854 filings